Business, energy, technology, markets and global industry news from Business News Today

Santen Pharmaceutical Co.

PharmaDeviceNews Santen Pharmaceutical Co.
An ophthalmic surgeon performs a glaucoma procedure as Glaukos Corporation advances the PRESERFLO MicroShunt through its U.S. pivotal study following completion of patient enrollment. Representative image.
Medical Devices & Diagnostics

Glaukos has enrolled the PRESERFLO pivotal study, but the decisive U.S. evidence is still ahead

Glaukos completes PRESERFLO pivotal enrollment, shifting focus to 12-month data, FDA clearance and advanced glaucoma adoption.

Read More